1991
DOI: 10.1007/bf02245652
|View full text |Cite
|
Sign up to set email alerts
|

Serotonin 5-HT3 antagonists do not alter the discriminative stimulus properties of cocaine

Abstract: The central nervous system (CNS) of the rat is known to contain serotonin (5-HT) type -3 receptors (5-HT3). Behavioral evidence suggests that 5-HT3 receptors interact with mesolimbic dopamine (DA) systems and that 5-HT3 antagonists can interfere with the hyperlocomotive effects of amphetamine and cocaine and the rewarding and stimulus effects of morphine, nicotine and ethanol. Cocaine, which blocks the reuptake of DA, norepinephrine (NE), and 5-HT in the CNS, also may be an antagonist at 5-HT3 receptors. The p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
21
1

Year Published

1992
1992
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(23 citation statements)
references
References 14 publications
1
21
1
Order By: Relevance
“…In self-administration and drug discrimination tests, however, 5-HT 3 receptor antagonists repeatedly failed to antagonize the effects of COC (Paris and Cunningham 1991;Peltier and Schenk 1991;Lane et al 1992). These results do not, however, necessarily conflict with each other.…”
Section: Discussionmentioning
confidence: 96%
“…In self-administration and drug discrimination tests, however, 5-HT 3 receptor antagonists repeatedly failed to antagonize the effects of COC (Paris and Cunningham 1991;Peltier and Schenk 1991;Lane et al 1992). These results do not, however, necessarily conflict with each other.…”
Section: Discussionmentioning
confidence: 96%
“…On the other hand, amphetamine and cocaine act directly on the dopaminergic synapse by displacing DA from synaptic terminals or by inhibiting synaptic reuptake; they do not produce increased firing of the dopaminergic neuron and thus they do not depend on presynaptic 5-HT3 receptors for their effects. This account is supported by electrophysiological and neurochemical evidence (see , but a difficulty arises from findings which appear to show that 5-HT 3 antagonists, whilst sparing the discriminative and rewarding properties of cocaine and amphetamine (Carboni et al, 1989 b;Paris and Cunningham, 1991;Peltier and Schenk, 1991), do block the locomotor stimulant and exploration-inducing properties of these drugs (Costall et al, 1987;van der Hoek and Cooper, 1990a, b). These findings are difficult to reconcile with the proposed presynaptic action of 5-HT3 antagonists, and the precise effects of 5.-HT3 antagonists on dopaminergic transmission remain uncertain.…”
Section: Introductionmentioning
confidence: 87%
“…Treatment with 5-HT 3 antagonists (ondansetron, ICS 205930 or MDL 72222) has been shown to inhibit hyperactivity elicited by the neurokinin analogue, DiMe-C 7 (Hagan et al, 1990), and to prevent the acquisition of habits conditioned to morphine, nicotine, phencyclidine, picrotoxin or naloxone (Carboni et al, 1989 b;Acquas et al, 1990;Higgins et al, 1992) though not amphetamine (Carboni et al, 1989 b) or cocaine (Paris and Cunningham, 1991;Peltier and Schenk, 1991; but cf. Costall et al, 1987).…”
Section: Introductionmentioning
confidence: 97%
“…The drug discrimination procedure has been used successfully to examine the role of various neurotransmitters, including 5HT, in the action of numerous drugs (Colpaert and Slangen 1982;Cunningham et al 1985;Colpaert and Balster 1988;Paris and Cunningham 1991). In addition, a large literature indicates that animals can be trained to discriminate between the presence and absence of ~c opioids, and the discriminative stimulus properties of the ~c opioids relate to their action at ~c opioid receptors (Hein et at.…”
mentioning
confidence: 98%